Foster GT, Varizi ND, Sassoon CS. Respiratory alkalosis. Respir Care. 2001;46:384-391.
Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002;347:43-53.
Seifter JL. Integration of acid-base and electrolyte disorders. N Engl J Med. 2014;371:1821-1831.
Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014;371:1434-1445.
Androgue HJ, Madias NE. Management of life-threatening acid-base disorders: second of two parts. N Engl J Med. 1998;338:107-111.
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228.
Solin P, Roebuck T, Johns DP, et al. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Resp Crit Care Med. 2000;162:2194-2200.
Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80:6-15.
Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med. 2010;38:1348-1359.
Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15:649-659.
O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. 2007;25:333-346.
1. Arbus GS, Herbert LA, Levesque PR, et al. Characterization and clinical application of the "significance band" for acute respiratory alkalosis. N Engl J Med. 1969;280:117-123.
2. Foster GT, Varizi ND, Sassoon CS. Respiratory alkalosis. Respir Care. 2001;46:384-391.
3. Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002;347:43-53.
4. Allen CH, Ward JD. An evidence-based approach to management of increased intracranial pressure. Crit Care Clin. 1998;14:485-495.
5. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105:14-20.
6. Hodgkin JE, Soeprono FF, Chan DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med. 1980;8:725-728.
7. Mazzara JT, Ayres SM, Grace WJ. Extreme hypocapnia in the critically ill patient. Am J Med. 1974;56:450-456.
8. Palange P, Carlone S, Galassetti P, et al. Incidence of acid-base and electrolyte disturbances in a general hospital: a study of 110 consecutive admissions. Recenti Prog Med. 1990;81:788-791.
9. Barillo DJ, Dickerson EE, Cioffi WG, et al. Pressure-controlled ventilation for the long-range aeromedical transport of patients with burns. J Burn Care Rehabil. 1997;18:200-205.
10. Hooper RG, Browning M. Acid-base changes and ventilator mode during maintenance ventilation. Crit Care Med. 1985;13:44-45.
11. Millar SM, Alston RP, Andrews PJ, et al. Cerebral hypoperfusion in immediate postoperative period following coronary artery bypass grafting, heart valve, and abdominal aortic surgery. Br J Anesth. 2001;87:229-236.
12. Marion DW, Spiegel TP. Changes in the management of severe traumatic brain injury: 1991-1997. Crit Care Med. 2000;28:16-18.
13. Huizenga JE, Zink B, Maio R, et al. The penetrance of head injury management guidelines into the practice patterns of Michigan emergency physicians. Acad Emerg Med. 2000;7:1171.
14. Rusnak M, Janciak I, Majdan M, et al. Severe traumatic brain injury in Austria VI: effects of guideline-based management. Wien Klin Wochenschr. 2007;119:64-71.
15. Latini G, Del Vecchio A, De Felice C, et al. Persistent pulmonary hypertension of the newborn: therapeutical approach. Mini Rev Med Chem. 2008;8:1507-1513.
16. Kelly LE, Ohlsson A, Shah PS. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2017;(8):CD005494.
17. Jacobson HR. Effects of CO2 and acetazolamide on bicarbonate and fluid transport in rabbit proximal tubules. Am J Physiol. 1981;240:F54-F62.
18. Seifter JL. Integration of acid-base and electrolyte disorders. N Engl J Med. 2014;371:1821-1831.
19. Santra G, Paul R, Das S, et al. Hyperventilation of pregnancy presenting with flaccid quadriparesis due to hypokalaemia secondary to respiratory alkalosis. J Assoc Physicians India. 2014;62:536-538
20. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014;371:1434-1445.
21. Gennari FJ, Goldstein MB, Schwartz WB. The nature of the renal adaptation to chronic hypocapnia. J Clin Invest. 1972;51:1722-1730.
22. Krapf R, Beeler I, Hertner D, et al. Chronic respiratory alkalosis: the effect of sustained hyperventilation on renal regulation of acid-base equilibrium. N Engl J Med. 1991;324:1394-1401.
23. Eldridge F, Salzer J. Effect of respiratory alkalosis on blood lactate and pyruvate in humans. J Appl Physiol. 1967;22:461-468.
24. Druml W, Grimm G, Laggner AN, et al. Lactic acid kinetics in respiratory acidosis. Crit Care Med. 1991;19:1120-1124.
25. Sakamoto A, Naito H, Chow CM. Hyperventilation as a strategy for improved repeated sprint performance. J Strength Cond Res. 2014;28:1119-1126.
26. Krapf R, Caduff P, Wagdi P, et al. Plasma potassium response to acute respiratory alkalosis. Kidney Int. 1995;47:217-224.
27. Sanchez MG, Finlayson DC. Dynamics of serum potassium change during acute respiratory alkalosis. Can Anaesth Soc J. 1978;25:495-498.
28. Brautbar N, Leibovici H, Massry SG. On the mechanism of hypophosphatemia during acute hyperventilation: evidence for increased muscle glycolysis. Miner Electrolyte Metab. 1983;9:45-50.
29. Hoppe A, Metler M, Berndt TJ. Effect of respiratory alkalosis on renal phosphate excretion. Am J Physiol. 1982;243:F471-F475.
30. Krapf R, Jaeger P, Hulter HN. Chronic respiratory alkalosis induces renal PTH-resistance, hyperphosphatemia, and hypocalcemia in humans. Kidney Int. 1992;42:727-734.
31. Jamison JP, Glover PJ, Wallace WF. Comparison of the effects of inhaled ipratropium bromide and salbutamol on the bronchoconstrictor response to hypocapnic hyperventilation in normal subjects. Thorax. 1987;42:809-814.
32. Rodriguez-Roisin R. Gas exchange abnormalities in asthma. Lung. 1990;168(Suppl):599-605.
33. Bayindir O, Akpinar B, Ozbek U, et al. The hazardous effects of alveolar hypocapnia on lung mechanics during weaning from cardiopulmonary bypass. Perfusion. 2000;15:27-31.
34. Fike CD, Hansen TN. The effect of alkalosis on hypoxia-induced vasoconstriction in lungs of newborn rabbits. Pediatr Res. 1989;25:383-388.
35. Samuelsson RG, Nagy G. Effects of respiratory alkalosis and acidosis on myocardial excitation. Acta Physiol Scand. 1976;97:158-165.
36. Neill WA, Hattenhauer M. Impairment of myocardial O2 supply due to hyperventilation. Circulation. 1975;52:854-858.
37. Morel J, Gergelé L, Dominé A, et al. The venous-arterial difference in CO2 should be interpreted with caution in case of respiratory alkalosis in healthy volunteers. J Clin Monit Comput. 2017;31:701-707.
38. Wildenthal K, Fuller DS, Shapiro W. Paroxysmal atrial arrhythmias induced by hyperventilation. Am J Cardiol. 1968;21:436-441.
39. Hisano K, Matsuguchi T, Ootsubo H, et al. Hyperventilation-induced variant angina with ventricular tachycardia. Am Heart J. 1984;108:423-425.
40. Brown EB Jr, Miller F. Ventricular fibrillation following a rapid fall in alveolar carbon dioxide concentration. Am J Physiol.1952;169:56-60.
41. Bharucha AE, Camilleri M, Ford MJ, et al. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology. 1996;111:368-377.
42. Ford MJ, Camelleri MJ, Hanson RB, et al. Hyperventilation, central autonomic control, and colonic tone in humans. Gut. 1995;37:499-504.
43. Rafferty GF, Saisch GN, Gardner WN. Relation of hypocapnic symptoms to rate of fall of end-tidal PCO2 in normal subjects. Respir Med. 1992;86:335-340.
44. Perkin GD, Joseph R. Neurological manifestations of the hyperventilation syndrome. J R Soc Med. 1986;79:448-450.
45. Gardner WN. The pathophysiology of hyperventilation disorders. Chest. 1996;109:516-534.
46. Macefield G, Burke D. Paraesthesiae and tetany induced by voluntary hyperventilation: increased excitability of human cutaneous and motor axons. Brain. 1991;114:527-540.
47. Edmondson JW, Brashear RE, Li TK. Tetany: quantitative interrelationships between calcium and alkalosis. Am J Physiol. 1975;228:1082-1086.
48. Kaehny WD. Respiratory acid-base disorders. Med Clin North Am. 1983;67:915-928.
49. Caruana-Montaldo B, Gleeson K, Zwillich CW. The control of breathing in clinical practice. Chest. 2000;117:205-225.
50. Grocott MP, Martin DS, Levett DZ, et al. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med. 2009;360:140-149.
51. Samaja M, Mariani C, Prestini A, et al. Acid-base balance and O2 transport at high altitude. Acta Physiol Scand. 1997;159:249-256.
52. Fan JL, Burgess KR, Basnyat R, et al. Influence of high altitude on cerebrovascular and ventilatory responsiveness to CO2. J Physiol. 2010;588:539-549.
53. Domino KB, Lu Y, Eisenstein BL, et al. Hypocapnia worsens arterial blood oxygenation and increases VA/Q heterogeneity in canine pulmonary edema. Anesthesiology. 1993;78:91-99.
54. Laffey JG, Engelberts D, Kavanagh BP. Injurious effects of hypocapnic alkalosis in the isolated lung. Am J Respir Crit Care Med. 2000;162:399-405.
55. Fujimori K, Satoh M, Arakawa M. Ventilatory response to continuous incremental changes in respiratory resistance in patients with mild asthma. Chest. 1996;109:1525-1531.
56. van den Elshout FJ, van Herwaarden CL, Folgering HT. Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects. Thorax. 1991;46:28-32.
57. Javaheri S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax. 1992;47:93-97.
58. Horrobin D, Cholmondeley HG. High altitude pulmonary oedema: pathophysiology and recommendations for prevention and treatment. East Afr Med J. 1972;49:327-331.
59. Trimble C, Smith DE, Rosenthal MH, et al. Pathophysiologic role of hypocarbia in post-traumatic pulmonary insufficiency. Am J Surg. 1971;122:633-638.
60. Mortelliti MP, Manning HL. Acute respiratory distress syndrome. Am Fam Physician. 2002;65:1823-1831.
61. Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000;342:868-874.
62. Subotic D, Mandaric D, Gajic M, et al. Uncertainties in the current understanding of gas exchange in spontaneous pneumothorax: effective lung ventilation may persist in a smaller-sized pneumothorax. Med Hypotheses. 2005;64:1144-1149.
63. Manganelli D, Palla A, Donnamaria V, et al. Clinical features of pulmonary embolism: doubts and certainties. Chest. 1995;107(suppl):25S-32S.
64. Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive clinical features of portopulmonary hypertension. Chest. 1997;112:980-986.
65. Jones PW, Huszczuk A, Wasserman K. Cardiac output as a controller of ventilation through changes in right ventricular load. J Appl Physiol. 1982;53:218-224.
66. Milsom WK, Sadig T. Interaction between norepinephrine and hypoxia on carotid body chemoreception in rabbits. J Appl Physiol. 1983;55:1893-1898.
67. Androgue HJ, Madias NE. Management of life-threatening acid-base disorders: second of two parts. N Engl J Med. 1998;338:107-111.
68. Bernstein D, Tripodi J. Fulminant hepatic failure. Crit Care Clin. 1998;14:181-197.
69. Brashear RE. Hyperventilation syndrome. Lung. 1983;161:257-273.
70. Nevin M, Colchester AC, Adams S, et al. Evidence for involvement of hypocapnia and hypoperfusion in aetiology of neurologic deficit after cardiopulmonary bypass. Lancet. 1987;2:1493-1495.
71. Graziani LJ, Gringlas M, Baumgart S. Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol. 1997;24:655-675.
72. Nazaroğlu H, Ozmen CA, Akay HO, et al. 64-MDCT pulmonary angiography and CT venography in the diagnosis of thromboembolic disease. Am J Roentgenol. 2009;192:654-661.
73. Blair E. Hypocapnia and gram-negative bacteremic shock. Am J Surg. 1970;119:433-439.
74. Hannart B. Pickett CK, Moore LG. Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia. J Appl Physiol. 1990;68:1909-1916.
75. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228.
76. Nystad D, Salvesen R, Nielsen EW. Brain stem encephalitis with central neurogenic hyperventilation. J Neurol Neurosurg Psychiatry. 2007;78:107-108.
77. Sears MR, O'Donoghue JM, Fisher HK, et al. Effect of experimental pneumococcal meningitis on respiration and circulation in the rabbit. J Clin Invest. 1974;54:18-23.
78. Tenholder MF, South-Paul JE. Dyspnea in pregnancy. Chest. 1989;96:381-388.
79. Wise RA, Polito AJ, Krishnan V. Respiratory physiologic changes in pregnancy. Immunol Allergy Clin N Am. 2006;26:1-12.
80. Damas-Mora J, Davies L, Taylor W, et al. Menstrual respiratory changes and symptoms. Br J Psychiatry. 1980;136:492-497.
81. Orr-Walker BJ, Horne AM, Evans MC, et al. Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women. J Clin Endocrinol Metab. 1999;84:1997-2001.
82. White MD. Components and mechanisms of thermal hyperpnea. J Appl Physiol. 2006;101:655-663.
83. Davis DP, Idris AH, Sise MJ, et al. Early ventilation and outcome in patients with moderate to severe traumatic brain injury. Crit Care Med. 2006;34:1202-1208.
84. Ogoh S, Nakahara H, Ainslie PN, et al. The effect of oxygen on dynamic cerebral autoregulation: critical role of hypocapnia. J Appl Physiol. 2010;108:538-543.
85. Pappas A, Shankaran S, Laptook AR, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2011;158:752-758.e1.
86. Tarulli AW, Lim C, Bui JD, et al. Central neurogenic hyperventilation: a case report and discussion of pathophysiology. Arch Neurol. 2005;62:1632-1634.
87. Lee MC, Klassen AC, Heaney LM, et al. Respiratory rate and pattern disturbances in acute brain stem infarction. Stroke. 1976;7:382-385.
88. Scialdone AM. Thalamic hemorrhage imitating hyperventilation. Ann Emerg Med. 1990;19:817-819.
89. Badr MS. Central sleep apnea. Prim Care Clin Office Pract. 2005;32:361-374.
90. Sung H, Sohn J, Kim J, et al. Acute respiratory alkalosis occurring after endoscopic third ventriculostomy: a case report. Korean J Anesthesiol. 2010;59(Suppl):S194-S196.
91. Solin P, Roebuck T, Johns DP, et al. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Resp Crit Care Med. 2000;162:2194-2200.
92. Xie A, Rutherford R, Rankin F, et al. Hypocapnia and increased ventilatory responsiveness in patients with idiopathic central sleep apnea. Am J Resp Crit Care Med. 1995;152:1950-1955.
93. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160:1101-1106.
94. Sankri-Tarbichi AG, Rowley JA, Badr MS. Expiratory pharyngeal narrowing during central hypocapnic hypopnea. Am J Respir Crit Care Med. 2009;179:313-319.
95. Tang GJ, Kou YR, Lin YS. Peripheral neural modulation of endotoxin-induced hyperventilation. Crit Care Med. 1998;26:1558-1563.
96. Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80:6-15.
97. Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med. 2010;38:1348-1359.
98. Moser KM, Luchsinger PC, Adamson JS, et al. Respiratory stimulation with intravenous doxapram in respiratory failure: a double-blind co-operative study. N Engl J Med. 1973;288:427-431.
99. Irwin GR Jr. Cerebrospinal fluid pH and respiratory rate in bacterial meningitis. Dis Nerv Syst. 1972;33:276-279.
100. Hornsveld HK, Garssen B, Dop MJ, et al. Double-blind placebo-controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. Lancet. 1996;348:154-158.
101. Zöphel K, Bacher-Stier C, Pinkert J, et al. Ventilation/perfusion lung scintigraphy: what is still needed? A review considering technetium-99m-labeled macro-aggregates of albumin. Ann Nucl Med. 2009;23:1-16.
102. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315-352.
103. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363:266-274.
104. Leigh-Smith S, Harris T. Tension pneumothorax - time for a re-think? Emerg Med J. 2005;22:8-16.
105. Ringleb PA, Schellinger PD, Schranz C, et al. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke. 2002;33:1437-1441.
106. Baringer JR. Herpes simplex infections of the nervous system. Neurol Clin. 2008;26:657-674.
107. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15:649-659.
108. Tylera KL. Neurological infections: advances in therapy, outcome, and prediction. Lancet Neurol. 2009;8:19-21.
109. O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. 2007;25:333-346.
110. Done AK. Aspirin overdosage: incidence, diagnosis, and management. Pediatrics. 1978;62(2 suppl):890S-897S.
111. Kulig K. Salicylate intoxication: is the Done nomogram reliable? [Comment in AACT] Clinical Toxicology UPDATE. 1990;3:2-3.
112. Kozaci N, Güngör F, Oguzhan Ay M, et al. Can venous blood gas values be used instead of arterial blood gas values in respiratory alkalosis? Turk J Biochem. 2014;39; 113-118.
113. Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589-602.
114. McConnell MV, Solomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol. 1996;78:469-473.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台